Exercise tolerance in asymptomatic patients with moderate-severe valvular heart disease and preserved ejection fraction

Archives of Medical Science

Volumn 8, Issue 6, 2012, Pages 1018-1026

  Olaf, Schulz ^a   Debora, Brala ^a   Ricarda, Bensch ^a   Gunnar, Berghöfer ^a   Jochen, Krämer ^a   Schimke, Ingolf ^b   Halle, Martin ^c   Jaffe, Allan ^d  

^a Interventionelle Kardiologie Spandau   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MAYO CLINIC   (United States)

Author keywords

Exercise tolerance; Spiroergometry; Troponin; Valvular heart disease

Indexed keywords

DOBUTAMINE; TROPONIN T;

ADULT; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BICYCLE ERGOMETRY; BLOOD SAMPLING; CARDIOPULMONARY HEMODYNAMICS; CEREBROVASCULAR ACCIDENT; CIRCULATION; DISEASE SEVERITY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; ISCHEMIA; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MYOCARDIAL DISEASE; POSTOPERATIVE PERIOD; PROGNOSIS; RESPIRATORY QUOTIENT; ST SEGMENT DEPRESSION; STRESS ECHOCARDIOGRAPHY;

EID: 84873178479     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.32409     Document Type: Article

References (36)

1. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
2. Schulz O, Rudolph A, Scheiner S, et al. Influence of acute and chronic myocardial loading conditions, function, structural changes and extracardiac factors on NT-proBNP in asymptomatic patients with preserved ejection fraction. Clin Res Cardiol 2011;100:57-65.
3. Gulati M, Black HR, Shaw LJ, et al. The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 2005;353:468-75. (Pubitemid 41127291)
4. Tabet JY, Beauvais F, Thabut G, Jm T, Logeart D, Cohen-Solal A. A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure. Eur J Cardiovasc Prevention Rehab 2003;10:267-72. (Pubitemid 37433491)
5. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
6. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550-8.
7. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler- catheterization study. Circulation 2000;102:1788-94.
8. Moller JE, Sondergaard E, Seward JB, Appleton CP, Egstrup K. Ratio of left ventricular peak E-wave velocity to flow propagation velocity assessed by color M-mode Doppler echocardiography in first myocardial infarction: prognostic and clinical implications. J Am Coll Cardiol 2000;35:363-70. (Pubitemid 30125526)
9. Iung B, Gohlke-Barwolf C, Tornos P, et al. Recom mendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 2002;23:1252-66.
10. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
11. Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002;106:3079-84. (Pubitemid 35440292)
12. Guazzi M, Myers J, Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 2005;46:1883-90. (Pubitemid 41579812)
13. Haluska BA, Short L, Marwick TH. Relationship of ventricular longitudinal function to contractile reserve in patients with mitral regurgitation. Am Heart J 2003;146:183-8. (Pubitemid 36851319)
14. Monin JL, Monchi M, Gest V, Duval-Moulin AM, Dubois-Rande JL, Gueret P. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol 2001;37:2101-7. (Pubitemid 32548004)
15. Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80.
16. Messika-Zeitoun D, Johnson BD, Nkomo V, et al. Cardiopulmonary exercise testing determination of func tional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol 2006;47:2521-7. (Pubitemid 43866363)
17. De Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
18. Arena R, Sietsema KE. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 2011;123:668-80.
19. Bjarnason-Wehrens B, Schulz O, Gielen S, et al. Leitlinie körperliche Aktivität zur Sekundärprävention und Therapie kardiovaskulärer Erkrankungen. Clin Res Cardiol 2009;4:1-44.
20. Arena R, Myers J, Williams MA, et al. Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation 2007;116:329-43. (Pubitemid 47196569)
21. Akin I, Kische S, Rehders TC, et al. Indication for percutaneous aortic valve implantation. Arch Med Sci 2010;6:296-302.
22. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001;103:2035-7. (Pubitemid 32373003)
23. Hessel MH, Atsma DE, Van Der Valk EJ, Bax WH, Schalij MJ, Van Der Laarse A. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch 2008;455:979-86. (Pubitemid 351169974)
24. Taniike M, Yamaguchi O, Tsujimoto I, et al. Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy. Circulation 2008;117:545-52.
25. Liu Q, Sargent MA, York AJ, Molkentin JD. ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice. Circ Res 2009;105:1110-7.
26. Chattopadhyay S, Alamgir MF, Nikitin NP, Rigby AS, Clark AL, Cleland JG. Lack of diastolic reserve in patients with heart failure and normal ejection fraction. Circ Heart Fail 2010;3:35-43.
27. Paulus WJ. Culprit mechanism (s) for exercise intolerance in heart failure with normal ejection fraction. J Am Coll Cardiol 2010;56:864-6.
28. Skaluba SJ, Litwin SE. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 2004;109:972-7. (Pubitemid 38282849)
29. Borlaug BA, Olson TP, Lam CS, et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010;56:845-54.
30. Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991;17:1065-72.
31. Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 2010;56:855-63.
32. Freimark D, Adler Y, Feinberg MS, et al. Impact of left ventricular filling properties on the benefit of exercise training in patients with advanced chronic heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2005;95:136-40. (Pubitemid 40051131)
33. Holland DJ, Kumbhani DJ, Ahmed SH, Marwick TH. Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction a meta-analysis. J Am Coll Cardiol 2011;57:1676-86.
34. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7. (Pubitemid 30659472)
35. Fedak PW, McCarthy PM, Bonow RO. Evolving concepts and technologies in mitral valve repair. Circulation 2008;117:963-74. (Pubitemid 351278391)
36. Aicher D, Holz A, Feldner S, Kollner V, Schafers HJ. Quality of life after aortic valve surgery: Replacement versus reconstruction. J Thorac Cardiovasc Surg 2011;142:e19-24.